IHS Chemical Week

Regions :: India/Pakistan

Cambrex Acquires Majority Stake in Indian Firm

10:04 PM MDT | November 2, 2010 | Deepti Ramesh

Cambrex (East Rutherford, NJ) says it has acquired a 51% stake in Zenara Pharma (Hyderabad, India), a pharmaceutical company focused on the formulation of final dosage form products, for $20 million. The company will be renamed Cambrex Zenara. Cambrex will acquire the remaining 49% stake in Zenara in early 2016, pursuant to the stock purchase agreement. The acquisition positions Cambrex as one of the leading global suppliers to the large and growing nicotine replacement therapy (NRT) market providing both active pharmaceutical ingredients (APIs) and finished...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa